on 20 Oct 2020
Last Applicant/ Owned by
and Business Building), 703-2,145, Anam
KR
Serial Number
79276524 filed on 29th Nov 2019
Registration Number
6177216 registered on 20th Oct 2020
Filing Basis
No Filing Basis
Disclaimer
NO DATA
Pharmaceutical agents affecting sensory organs; pharmaceutical preparations for the treatment of cerebral apoplexy; pharmaceutical agents affecting metabolism; pharmaceutical agents affecting peripheral nervous system; immunomodulators; anti-inflammatories; pharmaceutical agents affecting digestive organs; cardiovascular pharmaceutical preparations; pharmaceutical preparations for the treatment of Read More
Pharmaceutical agents affecting sensory organs; pharmaceutical preparations for the treatment of cerebral apoplexy; pharmaceutical agents affecting metabolism; pharmaceutical agents affecting peripheral nervous system; immunomodulators; anti-inflammatories; pharmaceutical agents affecting digestive organs; cardiovascular pharmaceutical preparations; pharmaceutical preparations for the treatment of deep vein thrombosis; drugs for medical purposes, namely, drugs for the treatment of cerebral apoplexy, drugs for affecting metabolism, drugs for affecting the peripheral nervous system, anti-inflammatory drugs, immunomodulatory drugs, cardiovascular drugs, drugs for treatment of deep vein thrombosis, drugs for treatment of systemic emboliform, drugs for treatment of venous thromboembolism, drugs affecting the central nervous system, drugs for treatment of pulmonary embolism, antibiotic drugs, drugs for the treatment of cancer, and drugs effecting respiratory organs; medicines for human purposes, namely, medicines for the treatment of cerebral apoplexy, medicines for affecting metabolism, medicines for affecting the peripheral nervous system, anti-inflammatory medicines, immunomodulatory medicines, cardiovascular medicines, medicines for treatment of deep vein thrombosis, medicines for treatment of systemic emboliform, medicines for treatment of venous thromboembolism, medicines affecting the central nervous system, medicines for treatment of pulmonary embolism, antibiotic medicines, medicines for the treatment of cancer or resistant cancer, and medicines effecting respiratory organs; pharmaceutical preparations for the treatment of systemic emboliform; pharmaceutical preparations for the treatment of venous thromboembolism; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for the treatment of pulmonary emboliform; antibiotics; anti-cancer preparations; pharmaceutical preparations for respiratory organs
No 79276524
No Service/Collective Mark
No 20-727
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
01st Mar 2021 | FINAL DECISION TRANSACTION PROCESSED BY IB |
07th Feb 2021 | FINAL DISPOSITION NOTICE SENT TO IB |
07th Feb 2021 | FINAL DISPOSITION PROCESSED |
20th Jan 2021 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
20th Oct 2020 | REGISTERED-PRINCIPAL REGISTER |
04th Aug 2020 | PUBLISHED FOR OPPOSITION |
04th Aug 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
31st Jul 2020 | NOTIFICATION PROCESSED BY IB |
15th Jul 2020 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
15th Jul 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |